期刊文献+

急性冠脉综合征患者经皮冠状动脉介入治疗后非罪犯血管病变进展危险因素及防治策略的研究进展 被引量:12

Research Progress on Risk Factors of Progression and Control Strategy of Non-culprit Coronary Lesions in Post-PCI Patients with Acute Coronary Syndrome
暂未订购
导出
摘要 45%以上的急性冠脉综合征(ACS)患者伴有多支血管病变(MVD),而非罪犯血管病变(NCCLs)进展与ACS伴MVD患者预后密切相关,减少NCCLs相关主要不良心血管事件(MACE)已成为改善ACS伴MVD患者预后的关键,但目前ACS患者罪犯血管行经皮冠状动脉介入治疗(PCI)后是否需进一步处理NCCLs及NCCLs的最佳血运重建时机仍存在一定争议。本文对ACS患者PCI后NCCLs进展的危险因素(包括血脂异常、炎症因素、糖代谢异常、肾功能异常、阻塞性睡眠呼吸暂停低通气综合征、代谢综合征、年龄、性别、斑块特征、病变位置及类型)及防治策略进行了综述,以期为更好地改善ACS患者预后提供参考。 There are more than 45%patients accompanied with multi-vessel diseases(MVD)in patients with acute coronary syndrome(ACS),however progression of non-culprit coronary lesions(NCCLs)is significantly associated with the prognosis of ACS patients complicated with MVD,reduce the risk of major adverse cardiovascular events(MACE)has become the key to improve the prognosis of such patients,but there is some controversy in necessity for intervention of NCCLs after intervention of culprit coronary lesions and the optimal opportunity for revascularization of NCCLs in patients with ACS so far.This paper reviewed the risk factors(including dyslipidemia,inflammatory factors,glucose metabolic abnormality,renal dysfunction,OSAHS,metabolic syndrome,age,gender,characteristics of plaques,locations and types of lesions)of progression and control strategy of NCCLs in post-PCI patients with ACS,in order to provide a reference for better improving the prognosis of such patients.
作者 姚冰琪 黄淑田 葛婕丽 台鸣娟 台润东 YAO Bingqi;HUANG Shutian;GE Jieli;TAI Mingjuan;TAI Rundong(Department of Cardiovascular Medicine,the Second Hospital of Shanxi Medical University,Taiyuan 030000,China)
出处 《实用心脑肺血管病杂志》 2020年第6期94-99,共6页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 冠心病 急性冠脉综合征 血管成形术 气囊 冠状动脉 非罪犯血管病变 危险因素 综述 Coronary disease Acute coronary syndrome Angioplasty balloon coronary Non-culprit coronary lesions Risk factors Review
  • 相关文献

参考文献9

二级参考文献54

  • 1韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:134
  • 2王广,毛节明,王宪,张福春.Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes[J].Chinese Medical Journal,2004(11):1650-1654. 被引量:32
  • 3ZheChen,Chun-shengLi,JianZhang,Bao-senPang,Cheng-qingXia,Xi-fengLiu.RELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND SERUM HOMOCYSTEINE IN PATIENTS WITH CORONARY LESIONS[J].Chinese Medical Sciences Journal,2005,20(1):63-66. 被引量:10
  • 4白怀生,常海强,侯艳峰,李毅,李小平,庞文跃,武治东.冠心病合并2型糖尿病患者生化指标与冠脉病变特点分析[J].疑难病杂志,2006,5(4):247-250. 被引量:2
  • 5Hsia J, Macfadyen JG, Monyak J, et al. Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cho- lesterol < 50 mg/dl with rosuvastatin. The Jupiter trial (Justification for the Use of Statins in Prevention : an Intervention Trial Evaluating Rosuv- astatin) [J]. J Am Coll: Cardiol,2011,57(16) :1666-1675.
  • 6Nicholls SJ,Ballantyne CM,Barter PJ,et al. Effect of two intensive sta- tin regimens on progression of coronary disease [ J ]. N Engl J Med, 201.1,365 (22) :2078-2087.
  • 7Han Y,Jing J, Tu S, et al. ST elevation acute myocardial infaretiou ac- celerates non-culprit coronary lesion atherosclemsis[ J]. Int J Cardiovasc hnaging,2014,30(2) :253-261.
  • 8Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction [ J ]. J Am Coil Cardio1,2005,46 ( 7 ) : 1225-1228.
  • 9Expert Dyslipidemia Panel of the Inte~national Atherosclerosis Society Panel Members. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia-fult report [J]. J Clin Lipidol,2014,8( 1 ) :29-60.
  • 10Pyxaras SA,Tu S, Barbato E,et al. Quantitative angiography and optical coherence tomograpby for the functional assessment of nonobstruciive eoronary stenoses: comparison with fractional flow reserve [ J]. Am Heart J,2013,166(6) :1010-1018. el.

共引文献82

同被引文献157

引证文献12

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部